{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:38:52Z","timestamp":1740155932215,"version":"3.37.3"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41582-020-00445-w","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T11:04:12Z","timestamp":1608289452000},"page":"71-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 and the neurological disease therapeutic pipeline"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-2166","authenticated-orcid":false,"given":"Gregory A.","family":"Jicha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin L.","family":"Abner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"445_CR1","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1161\/STROKEAHA.120.030417","volume":"51","author":"JP Broderick","year":"2020","unstructured":"Broderick, J. P. et al. National Institutes of Health StrokeNet during the time of COVID-19 and beyond. Stroke 51, 2580\u20132586 (2020).","journal-title":"Stroke"},{"key":"445_CR2","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s40520-020-01705-x","volume":"32","author":"EK Rhodus","year":"2020","unstructured":"Rhodus, E. K., Bardach, S. H., Abner, E. L., Gibson, A. & Jicha, G. A. COVID-19 and geriatric clinical trials research. Aging Clin. Exp. Res. 32, 2169\u20132172 (2020).","journal-title":"Aging Clin. Exp. Res."},{"key":"445_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-020-01089-6","volume":"20","author":"S Cro","year":"2020","unstructured":"Cro, S., Morris, T. P., Kahan, B. C., Cornelius, V. R. & Carpenter, J. R. A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic. BMC Med. Res. Methodol. 20, 208 (2020).","journal-title":"BMC Med. Res. Methodol."},{"key":"445_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JAD-200684","volume":"76","author":"SE Schindler","year":"2020","unstructured":"Schindler, S. E. et al. Maximizing safety in the conduct of alzheimer\u2019s disease fluid biomarker research in the era of COVID-19. J. Alzheimers Dis. 76, 27\u201331 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"445_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.18865\/ed.30.3.429","volume":"30","author":"DT Lackland","year":"2020","unstructured":"Lackland, D. T., Sims-Robinson, C., Jones Buie, J. N. & Voeks, J. H. Impact of COVID-19 on clinical research and inclusion of diverse populations. Ethn. Dis. 30, 429\u2013432 (2020).","journal-title":"Ethn. Dis."},{"key":"445_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/mus.26989","volume":"62","author":"JA Andrews","year":"2020","unstructured":"Andrews, J. A. et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities. Muscle Nerve 62, 182\u2013186 (2020).","journal-title":"Muscle Nerve"},{"key":"445_CR7","volume":"6","author":"SH Bardach","year":"2020","unstructured":"Bardach, S. H., Gibson, A. K., Rhodus, E. K. & Jicha, G. A. Will \u201csocial distancing\u201d lead to future \u201cresearch distancing\u201d: A reflection on COVID-19 impacts on Alzheimer\u2019s disease research. Alzheimers Dement. 6, e12045 (2020).","journal-title":"Alzheimers Dement."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41582-020-00445-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-020-00445-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-020-00445-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:12:30Z","timestamp":1684620750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-020-00445-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1038\/s41582-020-00445-w","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"type":"print","value":"1759-4758"},{"type":"electronic","value":"1759-4766"}],"subject":[],"published":{"date-parts":[[2020,12,18]]},"assertion":[{"value":"18 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.A.J. has received contract research funding from AbbVie, Biohaven, Eisai, Lilly, Neurovision, Novartis and Suven. E.L.A. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}